SG ID

SG00000295 

UniProt Accession

Q9VT60_DROME;Q9VT60;  

Theoretical PI

6.53  

Molecular Weight

96863 Da  

Genbank Nucleotide ID

AE014296; BT125951;  

Genbank Protein ID

AAF50194.3; ADX35930.1; 

Gene Name

iPLA2-VIA 

Gene Synonyms/Alias

iPLA2-VIA-RD 

Protein Name

 

Protein Synonyms/Alias

SubName: Calcium-independent phospholipase A2 VIA, isoform AEC=3.1.1.4SubName: LP03302p 

Drosophila melanogaster (Fruit fly) 

7227 

Temporarily unavailable 

The information of related literatures

1. A. Malhotra, I. Edelman-Novemsky, Y. Xu, H. Plesken, J. Ma, M. Schlame and M. Ren (2009) Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome. Proc Natl Acad Sci U S A 106(7): 2337-41. 

Abstract
Quantitative and qualitative alterations of mitochondrial cardiolipin have been implicated in the pathogenesis of Barth syndrome, an X-linked cardioskeletal myopathy caused by a deficiency in tafazzin, an enzyme in the cardiolipin remodeling pathway. We have generated and previously reported a tafazzin-deficient Drosophila model of Barth syndrome that is characterized by low cardiolipin concentration, abnormal cardiolipin fatty acyl composition, abnormal mitochondria, and poor motor function. Here, we first show that tafazzin deficiency in Drosophila disrupts the final stage of spermatogenesis, spermatid individualization, and causes male sterility. This phenotype can be genetically suppressed by inactivation of the gene encoding a calcium-independent phospholipase A(2), iPLA2-VIA, which also prevents cardiolipin depletion/monolysocardiolipin accumulation, although in wild-type flies inactivation of the iPLA2-VIA does not affect the molecular composition of cardiolipin. Furthermore, we show that treatment of Barth syndrome patients' lymphoblasts in tissue culture with the iPLA(2) inhibitor, bromoenol lactone, partially restores their cardiolipin homeostasis. Taken together, these findings establish a causal role of cardiolipin deficiency in the pathogenesis of Barth syndrome and identify iPLA2-VIA as an important enzyme in cardiolipin deacylation, and as a potential target for therapeutic intervention. PMID: [19164547] 

Figures for illustrating the function of this protein/gene

Function

 

Subcellular Location

 

Tissue Specificity

 

Gene Ontology

GO ID	GO term	Evidence
GO:0004623	F:phospholipase A2 activity	IEA:EC.
GO:0006629	P:lipid metabolic process	IEA:InterPro.

Back to Top

Interpro

IPR016035;    Acyl_Trfase/lysoPLipase.
IPR002110;    Ankyrin_rpt.
IPR020683;    Ankyrin_rpt-contain_dom.
IPR002641;    Patatin/PLipase_A2-rel.
Back to Top

Pfam

PF12796;    Ank_2;    3.
PF01734;    Patatin;    1.
Back to Top

SMART

SM00248;    ANK;    6.
Back to Top

PROSITE

PS50297;    ANK_REP_REGION;    1.
PS50088;    ANK_REPEAT;    3.
Back to Top

PRINTS

Back to Top

Created Date

18-Oct-2012 

Record Type

Experiment identified 

Protein sequence Annotation

Nucleotide Sequence

Length: bp   Go to nucleotide: FASTA

Protein Sequence

Length: 877 bp   Go to amino acid: FASTA

The verified Protein-Protein interaction information

UniProt	Gene Symbol	Ref Databases
Q9V504	_	MINT
A1Z7K8_DROME	CG8235	BioGRID

Other Protein-Protein interaction resources

String database  

UniProt

Gene Symbol

Ref Databases

View Microarray data

Temporarily unavailable 

Comments